Search results
Showing 631 to 645 of 687 results for must
Find out more about the types of organisations that can register to be a stakeholder at NICE.
Permission to use NICE content for artificial intelligence (AI) purposes
Permission form to use NICE content for artificial intelligence (AI) purposes.
development of such recommendations and guidelines and other information. 4. Users must only use the site for purposes consistent with...
Embed NICE content in your digital products and services with our syndication API.
have detailed any additional requirements and included them in the ITQ. You must also include details of how these will be evaluated....
A guide to the steps to follow when buying sole supplied titles from Lot 1 of our purchasing framework.
Charging procedure for NICE technology appraisal and highly specialised technologies evaluations
People have the right to be able to make informed decisions about their care. Our guidance should be taken into account when making decisions with them.
The principles that guide the development of NICE guidance and standards.
The benefits from donanemab (also called Kisunla and made by Eli Lilly) and lecanemab (also called Leqembi and made by Eisai) - remain too small to justify the additional cost to the NHS, one of our independent committees has concluded following consultation.
NICE's technology appraisal guidance makes recommendations on the use of new and existing medicines and other treatments within the NHS.
Four AI technologies conditionally recommended to help detect undiagnosed fragility fractures
The technologies could help healthcare professionals spot hidden spinal fractures in patients undergoing routine CT scans.
Training and development opportunities at NICE
The government uses a simple, but effective, model of the causes of health inequalities. This helps guide effective strategies to reduce them.
How to register with us as a diagnostic technologies stakeholder.